109 related articles for article (PubMed ID: 7911745)
1. In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse.
Kramer K; Azmitia EC; Whitaker-Azmitia PM
Brain Res Dev Brain Res; 1994 Mar; 78(1):142-6. PubMed ID: 7911745
[TBL] [Abstract][Full Text] [Related]
2. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Berger UV; Gu XF; Azmitia EC
Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
[TBL] [Abstract][Full Text] [Related]
3. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
Hekmatpanah CR; Peroutka SJ
Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
[TBL] [Abstract][Full Text] [Related]
4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
5. Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain.
Hashimoto K
Neurosci Lett; 1993 Apr; 152(1-2):17-20. PubMed ID: 7685864
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
McKenna DJ; Guan XM; Shulgin AT
Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
[TBL] [Abstract][Full Text] [Related]
7. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
Johnson MP; Conarty PF; Nichols DE
Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
[TBL] [Abstract][Full Text] [Related]
8. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
9. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Steele TD; Nichols DE; Yim GK
Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
[TBL] [Abstract][Full Text] [Related]
10. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Gu XF; Azmitia EC
Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens SA; Hata N; Cabrera T; Hamilton ME
NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
[No Abstract] [Full Text] [Related]
12. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
Johnson MP; Hoffman AJ; Nichols DE
Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735
[TBL] [Abstract][Full Text] [Related]
13. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
Wichems CH; Hollingsworth CK; Bennett BA
Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
[TBL] [Abstract][Full Text] [Related]
14. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
Rudnick G; Wall SC
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1817-21. PubMed ID: 1347426
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
Connor TJ; Kelly JP; Leonard BE
Immunopharmacology; 2000 Mar; 46(3):223-35. PubMed ID: 10741902
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices.
Fitzgerald JL; Reid JJ
Eur J Pharmacol; 1990 Nov; 191(2):217-20. PubMed ID: 1982265
[TBL] [Abstract][Full Text] [Related]
17. Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.
Schmidt CJ
Eur J Pharmacol; 1987 Apr; 136(1):81-8. PubMed ID: 2885204
[TBL] [Abstract][Full Text] [Related]
18. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Schmidt CJ; Black CK; Taylor VL
Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
Brodkin J; Malyala A; Nash JF
Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
